66-year-old male with prostate cancer undergoing active surveillance. Target lesions for Uronav. Biopsy showed Gleason grade 6 in the right lateral base, left medial and lateral base and left lateral mid gland. PELVIS:PROSTATE:Prostate Size: 6.1 x 4.5 x 5.6 cmPeripheral Zone: There are scattered foci of T2 to and ADC signal abnormality for example in the right mid gland where a small focus measures 2 x 2 mm (series 301/72). An additional punctate focus of signal abnormality left apex (series 508/164) may be an additional lesion versus periprosthetic vessels. Scattered areas of T1 hyperintensity are related to hemorrhage from prior biopsy. Central Gland: Benign prostatic hypertrophy.Seminal Vesicles: No evidence of seminal vesicle invasion.Extracapsular Extension: No extracapsular extension.BLADDER: No significant abnormality noted.LYMPH NODES: No pelvic lymphadenopathy.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Scattered foci of signal abnormality within the peripheral zone but no dominant lesion.PI-RADS™ v2 Assessment Categories:PIRADS 1 – Very low (clinically significant cancer is highly unlikely to be present) PIRADS 2 – Low (clinically significant cancer is unlikely to be present)PIRADS 3 – Intermediate (the presence of clinically significant cancer is equivocal)PIRADS 4 – High (clinically significant cancer is likely to be present) PIRADS 5 – Very high (clinically significant cancer is highly likely to be present)https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf